Program

Session 1:
Pediatric Tuberculosis and New development in the Pharmacokinectics and Pharmacodynamics of TB drugs.
Invited lecture by Dr. Peter Donald (Cape Town University, SA):
The PK and PD of antituberculosis drugs in children and adults; the way ahead in children.
+ abstract driven presentations

Session 2:
Pharmacokinectic and Pharmacodynamic Modeling.
Invited lecture by Dr. Hartmut Derendorf (University of Florida, USA):
PK-PD modeling: what can the TB field learn from other infectious diseases and cancer chemotherapy
+ abstract driven presentations

Session 3:
Pharmacokinectics and Pharmacodynamics of New and Approved drugs.
abstract driven presentations

Session 4:
Drug-Drug and Drug-Disease state interactions in TB.
Invited lecture by Dr Charles Peloquin (University of Florida, USA):
PK-PD mismatch in TB drug regimens
+ abstract driven presentations

Round Table discussion:
Controversies in Clinical Pharmacology of TB drugs